Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-041630
Filing Date
2017-06-23
Accepted
2017-06-23 16:03:51
Documents
2
Period of Report
2017-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 37026
2 POA DOCUMENT poa.txt EX-24.3_732986 2931
  Complete submission text file 0001209191-17-041630.txt   41291
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Issuer) CIK: 0000816284 (see all company filings)

EIN.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MYOVANT SCIENCES INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Business Address
Curran Terrie (Reporting) CIK: 0001690298 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34912 | Film No.: 17927600